Product
Anti-CD19-CAR
1 clinical trial
1 indication
Indication
LeukemiaClinical trial
Phase I Study of T Cells Expressing an Anti-CD19 Chimeric Receptor in Children and Young Adults With B Cell LeukemiaStatus: Not yet recruiting, Estimated PCD: 2023-08-01